Biography

Jeffrey L. Elliott, M.D., is a Professor in the Department of Neurology at UT Southwestern Medical Center. He specializes in neuromuscular disorders.

Dr. Elliott earned his medical degree at Washington University School of Medicine in St. Louis. He completed a residency in neurology at Barnes-Jewish Hospital and received advanced training through a neuromuscular disease fellowship at Washington University Medical Center.

Certified by the American Board of Psychiatry and Neurology and the American Board of Electrodiagnostic Medicine, he joined the UT Southwestern faculty in 1997.

Dr. Elliott is head of the neuromuscular section of the neuromuscular division in the Department of Neurology and is Director of the MDA/ALS Clinic at UT Southwestern. He’s a member of the American Academy of Neurology, the American Neurological Association, and the American Association of Neuromuscular & Electrodiagnostic Medicine. In 2018, he earned the Trephined Cranium Award for Excellence in Neurology Teaching.

Education

Medical School
Washington University School of Medicine (1988)
Internship
Jewish Hospital of St. Louis (1989), Internal Medicine
Residency
Barnes-Jewish Hospital (1992), Neurology
Fellowship
Washington University in St. Louis (1994), Neuromuscular Disease

Research Interest

  • Amyotrophic Lateral Sclerosis; Energetics

Publications

Featured Publications LegendFeatured Publications

Aggregate formation in the spinal cord of mutant SOD1 transgenic mice is reversible and mediated by proteasomes.
Puttaparthi K, Wojcik C, Rajendran B, DeMartino GN, Elliott JL J. Neurochem. 2003 Nov 87 4 851-60
Aggregate formation in Cu,Zn superoxide dismutase-related proteins.
Son M, Cloyd CD, Rothstein JD, Rajendran B, Elliott JL J. Biol. Chem. 2003 Apr 278 16 14331-6
Disease progression in a transgenic model of familial amyotrophic lateral sclerosis is dependent on both neuronal and non-neuronal zinc binding proteins.
Puttaparthi K, Gitomer WL, Krishnan U, Son M, Rajendran B, Elliott JL J. Neurosci. 2002 Oct 22 20 8790-6
Cytokine upregulation in a murine model of familial amyotrophic lateral sclerosis.
Elliott JL Brain Res. Mol. Brain Res. 2001 Nov 95 1-2 172-8
Survival in a transgenic model of FALS is independent of iNOS expression.
Son M, Fathallah-Shaykh HM, Elliott JL Ann. Neurol. 2001 Aug 50 2 273
Zinc and copper in the pathogenesis of amyotrophic lateral sclerosis.
Elliott JL Prog. Neuropsychopharmacol. Biol. Psychiatry 2001 Aug 25 6 1169-85
Glutamate transporter EAAT2 splice variants occur not only in ALS, but also in AD and controls.
Honig LS, Chambliss DD, Bigio EH, Carroll SL, Elliott JL Neurology 2000 Oct 55 8 1082-8
Metallothionein expression is altered in a transgenic murine model of familial amyotrophic lateral sclerosis.
Gong YH, Elliott JL Exp. Neurol. 2000 Mar 162 1 27-36
Restricted expression of G86R Cu/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration.
Gong YH, Parsadanian AS, Andreeva A, Snider WD, Elliott JL J. Neurosci. 2000 Jan 20 2 660-5
Experimental models of amyotrophic lateral sclerosis.
Elliott JL Neurobiol. Dis. 1999 Oct 6 5 310-20

Books

Featured Books Legend Featured Books

Honors & Awards

  • Trephined Cranium Award for Excellence in Neurology Teaching
    Awarded for recognition for excellence in Neurology teaching by neurology residents (2018-2019)
  • President Research Council Distinguished Young Researcher Award
    (1998)

Professional Associations/Affiliations

  • American Neurological Association (2005-2020)
  • American Academy of Neurology
  • American Association of Electrodiagnostic Medicine